Feb 04, 2021
Astellas expands Top Management, names Percival Barretto-Ko as Chief Business Officer; Yoshitsugu Shitaka as Chief Scientific Officer
Oct 28, 2020
Astellas Receives U.S. FDA Fast Track Designation for ASP5354, an Investigational Near-Infrared Fluorescence Imaging Agent
Apr 02, 2020
Astellas Pharma US and Astellas Global Health Foundation COVID-19 Pandemic Response
Mar 31, 2020
Amgen Establishes Wholly-Owned Affiliate In Japan
Feb 10, 2020
Astellas Global Health Foundation and AMPATH Announce a Three-Year $1.35 Million Grant to Aid Mental Health Programming in Western Kenya
Feb 10, 2020
Seattle Genetics and Astellas Announce Updated Results from Phase 1b/2 Trial of PADCEV(TM) (enfortumab vedotin-ejfv) in Combination with Immune Therapy Pembrolizumab as Investigational First-Line Treatment for Advanced Bladder Cancer
Jan 21, 2020
Six Years of Perfect Equality Scores on CEI Index a Testament to Astellas' Culture of Inclusion
Dec 26, 2019
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
Dec 16, 2019
XTANDI® (enzalutamide) Approved by U.S. FDA for the Treatment of Metastatic Castration-Sensitive Prostate Cancer
Dec 05, 2019
Astellas and MBC BioLabs Announce Golden Ticket Winners - Supporting Biotech Start-Ups to Accelerate Innovative Science
Nov 25, 2019
Astellas Announces the Approval of XTANDI® (enzalutamide) by the China National Medical Products Administration (NMPA)
Oct 10, 2019
Astellas earns spot on Working Mother's Best Companies for Dads List
Sep 28, 2019
Seattle Genetics and Astellas Announce Results from Phase 1 Trial of Investigational Agent Enfortumab Vedotin in Combination with Immune Therapy Pembrolizumab as First-Line Treatment for Advanced Bladder Cancer
Sep 24, 2019
Astellas ranks in Top 10 of Working Mother Best Companies list
Sep 20, 2019
Astellas Receives Positive CHMP Opinion for XOSPATA® (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
Sep 18, 2019
Astellas Celebrates Decade of Service by Volunteering 80,000 Hours to Help Local Communities
Sep 11, 2019
Astellas Partners with MBC BioLabs to Help Pioneering Biotech Start-ups Accelerate Early Drug Discovery and Research Efforts
May 09, 2019
Astellas' Chelsea Glinski Named a 2019 Healthcare Businesswomen's Association Luminary
Feb 20, 2019
Astellas and WiserCare Announce Collaboration to Improve Patient Experience
Dec 12, 2018
Astellas Promotes Lei Ding to vice president, Payer Strategy, Contracts, and Pricing